In a recent decision issued by the Central Division of the Unified Patent Court in Paris, the European patent (EP 3 646 825) was partially revoked.
The case centers around a European patent (EP 3 646 825), focusing on a prosthetic heart valve system. Meril Italy initiated a revocation action, claiming the patent should be invalidated for multiple reasons, including extension of the subject matter, lack of novelty and lack of inventive step.
A significant procedural step was the consolidation of separate revocation (counter) actions brought forth not only by Meril Italy but also by related entities before the Local Division Munich (which referred the counter claims to the Central Division). This consolidation aimed to streamline proceedings and reduce the risk of inconsistent decisions across divisions, enhancing procedural efficiency and judicial coherence.
The Paris division identified an "inadmissible intermediate generalization" in the patent claim, aligning closely with a parallel decision by the European Patent Office (EPO). This suggests further that the UPC's standards and reasoning are closely aligned with those of the EPO.
Intriguingly, the Unified Patent Court chose not to use the "problem-solution approach" typically employed by the EPO in evaluating patent validity. Nonetheless, the court mentioned in a side note that even if the problem-solution approach had been applied, it would not have altered the outcome of the decision.